Thymosin-α1

DRUG2 trials

Sponsors

Zhigang Zhang, Sun Yat-sen University

Conditions

Cancer Related FatigueLiver FailureQuality of Life

Phase 3

Thymosin-α1 in Cancer-Related Fatigue

Zhigang ZhangCancer Related Fatigue, Quality of Life

Start: 2014-04-30End: 2020-12-31Target: 200Updated: 2019-04-10

Unknown Phase

The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF

CompletedNCT03082885

Sun Yat-sen UniversityLiver Failure

Start: 2017-04-10End: 2019-07-30Updated: 2021-08-16

Related Papers

Thymosin α1 improves the outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure by restoring immune balance.

2026-03-26

Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial.

2022-05-264 citations